INTERMUNE INC
DelistedCIK 1087432fmd_024WQW082FVVG11RPH1RMN6AR7Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2014, 19 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|
| Total revenues | 49 | – | 5 | 26 | 70 |
| Cost of revenue | 7 | 6 | 1 | 9 | 10 |
| Gross profit | 42 | – | 4 | 17 | 60 |
| Realized investment gains (losses) | 7 | 1 | – | – | – |
| Research and development | 89 | 67 | 75 | 107 | 114 |
| Selling, general and administrative | 37 | 55 | 89 | 105 | 145 |
| Operating income | (101) | 115 | (160) | (195) | (199) |
| Interest expense | 10 | 8 | 6 | 9 | 15 |
| Interest and investment income | 2 | 1 | 1 | 1 | 0 |
| Other non-operating income (expense) | 6 | 2 | (1) | (0) | (2) |
| Income before taxes | (114) | 109 | (167) | (203) | (220) |
| Income tax expense | 2 | 0 | (5) | (19) | 1 |
| Net income from continuing operations | (116) | 109 | (162) | (185) | (221) |
| Net income | (116) | 122 | (155) | (150) | (220) |
| Net income to common shareholders | (116) | 122 | (155) | (150) | – |